FITY (Fifty 1 Labs) Current Deferred Revenue: $0.00 Mil (As of Jun. 2024)


What is Fifty 1 Labs Current Deferred Revenue?

Fifty 1 Labs FITY +20.00% Current Deferred Revenue is $0.00 Mil as of Jun. 2024.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Fifty 1 Labs's current deferred revenue for the quarter that ended in Jun. 2024 was $0.00 Mil.

Fifty 1 Labs Current Deferred Revenue Related Terms

Fifty 1 Labs Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Fifty 1 Labs's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fifty 1 Labs Current Deferred Revenue Chart

Fifty 1 Labs Annual Data
Trend Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fifty 1 Labs Semi-Annual Data
Dec03 Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
What does a Current Deferred Revenue of $0.00 Mil mean?
Fifty 1 Labs (FITY) has a Current Deferred Revenue of $0.00 Mil as of Jun. 2024. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Fifty 1 Labs and its competitors.
Is Fifty 1 Labs' Current Deferred Revenue too high?
Fifty 1 Labs' current Current Deferred Revenue is $0.00 Mil.
How does Fifty 1 Labs' Current Deferred Revenue compare to GRPS and KOAN?
Fifty 1 Labs' Current Deferred Revenue of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Drug Manufacturers company?
A good Current Deferred Revenue depends on the Drug Manufacturers industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Fifty 1 Labs and its competitors. Fifty 1 Labs's current Current Deferred Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fifty 1 Labs stock overvalued right now?
Fifty 1 Labs (FITY) has a current Current Deferred Revenue of $0.00 Mil. The current Current Deferred Revenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Fifty 1 Labs (FITY), the current Current Deferred Revenue is $0.00 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fifty 1 Labs Business Description

Address 1505 West 2nd Avenue, Suite 506, Melbourne, FL, USA, V6J 1H2
Fifty 1 Labs Inc is a holding company with subsidiaries that operate in the sports supplement, fitness equipment, and health and wellness industries, respectively. The company offers a line of supplements - including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies - designed to enhance athletic performance, recovery, and overall health.